Summit Therapeutics Newsroom

Jefferies Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $44

Moomoo News14:31 ET · Ratings

H.C. Wainwright Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $44

Moomoo News14:31 ET · Ratings

Cantor Fitzgerald Maintains Summit Therapeutics(SMMT.US) With Buy Rating

Moomoo News14:31 ET · Ratings

Express News | Goldman Sachs Maintains Buy on Summit Therapeutics, Raises Price Target to $41

Benzinga13:02 ET

Summit Therapeutics Analyst Ratings

Benzinga13:01 ET · Ratings

Trending Stocks Today | Polyrizon Shoots up 217.71%

Moomoo NewsMay 2 10:55 ET

US MOVERS&SHAKERS Apr 28-May 02, 2025

Moomoo NewsMay 2 04:15 ET · Markets

Earnings Call Summary | Summit Therapeutics(SMMT.US) Q1 2025 Earnings Conference

moomoo AIMay 2 01:23 ET · Conference Call

Summit Therapeutics Outlines Ivonescimab Progress With Key Phase III Data Expected Mid-2025

Seeking AlphaMay 2 01:07 ET

Summit Therapeutics Non-GAAP EPS of -$0.07 Beats by $0.02

Seeking AlphaMay 1 16:43 ET

Summit Therapeutics Q1 Loss Widens; Cash Equivalents Drop

MT NewswiresMay 1 16:32 ET

Earnings Flash (SMMT) Summit Therapeutics Q1 Adjusted Loss $0.07 Vs. $0.05 Loss Year Ago

MT NewswiresMay 1 16:17 ET

Summit Therapeutics | 10-Q: Q1 2025 Earnings Report

SECMay 1 16:12 ET · Announcements

Express News | Summit Therapeutics Q1 Operating Expenses USD 66.8 Million

ReutersMay 1 16:09 ET

Express News | Summit Therapeutics Q1 EPS USD -0.09

ReutersMay 1 16:09 ET

Express News | Summit Therapeutics Q1 Net Income USD -62.9 Million

ReutersMay 1 16:09 ET

Summit Therapeutics Options Imply 6.7% Move in Share Price Post-earnings

TipRanksMay 1 14:20 ET

Earnings Scheduled For May 1, 2025

BenzingaMay 1 04:32 ET

Summit Therapeutics Q1 2025 Earnings Preview

Seeking AlphaApr 30 15:16 ET

Summit Therapeutics (NasdaqGM:SMMT) Sees 16% Stock Price Increase Over Past Month

Yahoo FinanceApr 30 13:56 ET